DHR

#112
Danaher Corporation Common Stock
182.6 8 USD
+1.38%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
182.36
183.46
Range Annuel
160.93
242.75
Changement quotidien
+1.38%
Changement Mensuel
+2.06%
Evolution sur 6 mois
-19.38%
Changement Annuel
-4.05%
Clôture Précédente
180.1 9
Open
183.1 4
Low
182.3 6
High
183.4 6
Volume
2 212
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 129.3 B
  • Employee 60 K
  • Founded N/A
  • CEO Rainer M. Blair
  • Website www.danaher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BH3JF8
  • Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
45.33
ratio cours/chiffre d'affaires
6.67

Danaher Corporation Common Stock

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.

Nouvelles